UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.263

Sortiert nach

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1128-1135

1996

Link zum Volltext

Verfügbarkeit prüfen

Cardiac arrest in private locations: different strategies are needed to improve outcome

Resuscitation, 2003-08, Vol.58 (2), p.171-176

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase I and pharmacokinetic trial of weekly CPT-11

Journal of clinical oncology, 1993-11, Vol.11 (11), p.2194-2204

1993

Link zum Volltext

Verfügbarkeit prüfen

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy

Breast cancer research and treatment, 2006, Vol.95 (1), p.13-16

2006

Link zum Volltext

Verfügbarkeit prüfen

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2842-2850

1995

Link zum Volltext

Verfügbarkeit prüfen

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Cancer chemotherapy and pharmacology, 1999, Vol.44 (5), p.372-380

1999

Link zum Volltext

Verfügbarkeit prüfen

Fluorouracil and the new oral fluorinated pyrimidines

The Annals of pharmacotherapy, 2001-02, Vol.35 (2), p.217

Kuhn, J G

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2188-2194

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Annals of oncology, 2001-11, Vol.12 (11), p.1631-1641

2001

Link zum Volltext

Verfügbarkeit prüfen

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-05, Vol.19 (3), p.409-414

2013

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V‐stabilizing fab

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.941-947

2017

Link zum Volltext

Verfügbarkeit prüfen

Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.148-151

2016

Link zum Volltext

Verfügbarkeit prüfen

Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro

JNCI : Journal of the National Cancer Institute, 1992-12, Vol.84 (23), p.1816-1820

1992

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

Journal of clinical oncology, 1999-02, Vol.17 (2), p.685-696

1999

Link zum Volltext

Verfügbarkeit prüfen

A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies

Clinical cancer research, 1998-11, Vol.4 (11), p.2763-2770

1998

Link zum Volltext

Verfügbarkeit prüfen

9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice

Clinical cancer research, 2000-09, Vol.6 (9), p.3696-3704

2000

Link zum Volltext

Verfügbarkeit prüfen

Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.1977-1983

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of itraconazole following oral administration to normal volunteers

Antimicrobial Agents and Chemotherapy, 1988-09, Vol.32 (9), p.1310-1313

1988

Link zum Volltext

Verfügbarkeit prüfen

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide

Clinical cancer research, 1998-06, Vol.4 (6), p.1459-1467

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4086-4097

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks

Clinical cancer research, 1998-03, Vol.4 (3), p.595-604

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1095-1104

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report

Journal of clinical oncology, 1999-03, Vol.17 (3), p.984-990

1999

Link zum Volltext

Verfügbarkeit prüfen

Monitoring rFVIIa 90 μg kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.949

2011

Link zum Volltext

Verfügbarkeit prüfen

Faculty Development: The Educator's Portfolio: Its Preparation, Uses, and Value in Academic Medicine

Academic emergency medicine, 2004-03, Vol.11 (3), p.307-311

Kuhn, G. J.

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.610)
Mit Volltextzugriff
(3.736)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.368)
Life Sciences & Biomedicine
(1.502)
Humans
(1.206)
Female
(727)
Physical Sciences
(711)
Male
(654)
Physics
(603)
Biological And Medical Sciences
(574)
Animals
(478)
Middle Aged
(471)
Adult
(464)
Medical Sciences
(404)
Aged
(323)
Technology
(292)
Oncology
(225)
Medicin Och Hälsovetenskap
(206)
Fundamental And Applied Biological Sciences. Psychology
(200)
Exact Sciences And Technology
(174)
Pharmacology. Drug Treatments
(162)
Biochemistry & Molecular Biology
(153)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Cardiac arrest in private locations: different strategies are needed to improve outcome

Phase I and pharmacokinetic trial of weekly CPT-11

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Fluorouracil and the new oral fluorinated pyrimidines

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V‐stabilizing fab

Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?

Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies

9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice

Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)

Pharmacokinetics of itraconazole following oral administration to normal volunteers

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide

Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks

Phase I and Pharmacologic Study of the Tyrosine Kinase Inhibitor SU101 in Patients With Advanced Solid Tumors

Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report

Monitoring rFVIIa 90 μg kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

Faculty Development: The Educator's Portfolio: Its Preparation, Uses, and Value in Academic Medicine

Suchergebnisse filtern